BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 27109807)

  • 1. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-2 expression in patients with an acute exacerbation of idiopathic interstitial pneumonias.
    Ando M; Miyazaki E; Abe T; Ehara C; Goto A; Masuda T; Nishio S; Fujisaki H; Yamasue M; Ishii T; Mukai Y; Ito T; Nureki SI; Kumamoto T; Kadota J
    Respir Med; 2016 Aug; 117():27-32. PubMed ID: 27492510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.
    Matsuzawa Y; Kawashima T; Kuwabara R; Hayakawa S; Irie T; Yoshida T; Rikitake H; Wakabayashi T; Okada N; Kawashima K; Suzuki Y; Shirai K
    Pulm Pharmacol Ther; 2015 Jun; 32():1-6. PubMed ID: 25862941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis.
    Fahim A; Crooks MG; Wilmot R; Campbell AP; Morice AH; Hart SP
    Respirology; 2012 Nov; 17(8):1247-52. PubMed ID: 22816375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
    Callahan SJ; Xia M; Murray S; Flaherty KR
    Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.
    Kondoh Y; Taniguchi H; Ogura T; Johkoh T; Fujimoto K; Sumikawa H; Kataoka K; Baba T; Colby TV; Kitaichi M
    Respirology; 2013 Jul; 18(5):820-6. PubMed ID: 23489318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of angiogenin in predicting the prognosis of patients with idiopathic pulmonary fibrosis].
    Bai Y; Zhu H; Sun Q; Gu G; Zhang L; Li Y; Yang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):789-793. PubMed ID: 28936953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
    Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
    Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.
    Strand MJ; Sprunger D; Cosgrove GP; Fernandez-Perez ER; Frankel SK; Huie TJ; Olson AL; Solomon J; Brown KK; Swigris JJ
    Chest; 2014 Sep; 146(3):775-785. PubMed ID: 24700149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
    Enomoto N; Suzuki S; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Fujisawa T; Nakamura Y; Odagiri K; Ishikawa T; Kataoka K; Kondoh Y; Maekawa M; Inui N; Watanabe H; Suda T
    Sci Rep; 2021 Jul; 11(1):15502. PubMed ID: 34326408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.